Nexalin Technology, Inc.
NXL- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001527352
No open-market purchases or sales by Nexalin Technology, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $281.6K in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Nexalin Technology, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −3 vs. Q1 2026
- Shares held
- 848.5K
- −217.4K (−20.4%) vs. Q1 2026
- Total value
- $281.6K
- −$91.9K (−24.6%) vs. Q1 2026
- New holders
- 4
- 2 more added
- Sold out
- 7
- 5 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NXL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $281.6K |
| Q1 2026 | 23 | $373.6K |
| Q4 2025 | 19 | $682.6K |
| Q3 2025 | 20 | $638.3K |
| Q2 2025 | 21 | $1.31M |
| Q1 2025 | 17 | $774.5K |
| Q4 2024 | 19 | $1.04M |
| Q3 2024 | 15 | $286.8K |
| Q2 2024 | 13 | $466.9K |
| Q1 2024 | 5 | $88.9K |
| Q4 2023 | 3 | $18.3K |
| Q3 2023 | 5 | $36.0K |
| Q2 2023 | 4 | $11.0K |
| Q1 2023 | 7 | $45.5K |
| Q4 2022 | 7 | $32.5K |
| Q3 2022 | 2 | $21.0K |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Nexalin Technology, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 241 | $80 | 0.00% | +241 | New |
| Federation des caisses Desjardins du Quebec | 873 | $288 | 0.00% | +873 | New |
| Farther Finance Advisors, LLC | 1,000 | $330 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,000 | $330 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,459 | $481 | 0.00% | +1,459 | New |
| Advisor Group Holdings, Inc. | 2,100 | $693 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,111 | $697 | 0.00% | −10.0% | Reduced |
| Integrated Investment Consultants, LLC | 10,000 | $3.30K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Inc | 12,100 | $3.99K | 0.00% | 00.0% | Unchanged |
| StoneX Group Inc. | 13,497 | $5.41K | 0.00% | −9,426−41.1% | Reduced |
| Northern Trust Corp | 24,100 | $7.95K | 0.00% | 00.0% | Unchanged |
| Kovack Advisors, Inc. | 22,325 | $8.04K | 0.00% | −1,000−4.3% | Reduced |
| UBS Group AG | 26,825 | $8.85K | 0.00% | +4,636+20.9% | Added |
| State Street Corp | 32,300 | $10.7K | 0.00% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 51,386 | $17.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 65,497 | $21.6K | 0.00% | +54,987+523.2% | Added |
| Citadel Advisors LLC | 75,398 | $24.9K | 0.00% | +75,398 | New |
| Vanguard Capital Management LLC | 126,536 | $41.8K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 139,583 | $46.1K | 0.00% | −107,454−43.5% | Reduced |
| PEAK6 LLC | 240,210 | $79.3K | 0.00% | −144,250−37.5% | Reduced |
| HRT Financial LP | 0 | $0 | 0.00% | −23,453−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −20,928−100.0% | Sold out |
| Elevation Advisory Partners LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −15,901−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −10,676−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −10,447−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |